$BPTH
BIO-PATH HOLDINGS, INC.

2019 Q2 Form 10-Q Financial Statement

#000114420419026590 Filed on May 15, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q4
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $970.0K $1.120M $800.0K
YoY Change 14.12% 13.13% -2.44%
% of Gross Profit
Research & Development $1.520M $398.0K $500.0K
YoY Change 83.8% -57.3% -64.03%
% of Gross Profit
Depreciation & Amortization $30.00K $66.00K $110.0K
YoY Change -70.0% 0.0% 10.0%
% of Gross Profit
Operating Expenses $2.490M $1.520M $1.300M
YoY Change 48.3% -20.79% -41.18%
Operating Profit -$1.520M
YoY Change -20.79%
Interest Expense $30.00K $10.00K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $8.000K $0.00
YoY Change 166.67%
Pretax Income -$2.460M -$1.510M -$1.910M
YoY Change 46.43% -21.35% -11.98%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.460M -$1.512M -$1.910M
YoY Change 46.69% -21.09% -11.98%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$869.3K -$888.2K -$2.809M
COMMON SHARES
Basic Shares Outstanding 2.831M 2.507M 13.60M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.11M $19.28M $1.000M
YoY Change 563.18% 350.47% -83.25%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $1.500M $1.163M $593.0K
YoY Change 148.34% -26.86% 67.99%
Inventory
Prepaid Expenses $427.0K $332.0K
Receivables
Other Receivables
Total Short-Term Assets $18.61M $20.87M $1.929M
YoY Change 312.27% 255.47% -74.06%
LONG-TERM ASSETS
Property, Plant & Equipment $710.0K $340.0K $406.0K
YoY Change 31.73% -43.8% -37.92%
Goodwill
YoY Change
Intangibles $0.00
YoY Change -100.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $710.0K $453.0K $406.0K
YoY Change -42.18% -65.94% -71.47%
TOTAL ASSETS
Total Short-Term Assets $18.61M $20.87M $1.929M
Total Long-Term Assets $710.0K $453.0K $406.0K
Total Assets $19.32M $21.32M $2.335M
YoY Change 236.47% 196.1% -73.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $440.0K $607.0K $813.0K
YoY Change 221.17% 333.57% 1463.46%
Accrued Expenses $590.0K $456.0K $304.0K
YoY Change -32.03% -42.28% -58.86%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.030M $1.117M $1.117M
YoY Change 2.49% 20.11% 41.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $370.0K $60.00K $0.00
YoY Change
Total Long-Term Liabilities $370.0K $60.00K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.030M $1.117M $1.117M
Total Long-Term Liabilities $370.0K $60.00K $0.00
Total Liabilities $1.410M $1.176M $1.117M
YoY Change 40.3% 26.45% 41.21%
SHAREHOLDERS EQUITY
Retained Earnings -$49.25M -$47.74M
YoY Change 21.92%
Common Stock $3.000K $1.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.91M $20.14M $1.218M
YoY Change
Total Liabilities & Shareholders Equity $19.32M $21.32M $2.335M
YoY Change 236.47% 196.1% -73.64%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$2.460M -$1.512M -$1.910M
YoY Change 46.69% -21.09% -11.98%
Depreciation, Depletion And Amortization $30.00K $66.00K $110.0K
YoY Change -70.0% 0.0% 10.0%
Cash From Operating Activities -$2.210M -$2.008M -$1.280M
YoY Change 29.24% 20.67% -42.6%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $19.41M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 50.00K 20.28M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.210M -2.008M -1.280M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 50.00K 20.28M 0.000
Net Change In Cash -2.160M 18.27M -1.280M
YoY Change 26.32% -1186.97% -195.52%
FREE CASH FLOW
Cash From Operating Activities -$2.210M -$2.008M -$1.280M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$2.210M -$2.008M -$1.280M
YoY Change 29.24% 19.45% -42.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Assets Current
AssetsCurrent
20866000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
1929000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
998000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
998000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
658000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
592000
CY2019Q1 us-gaap Assets
Assets
21319000
CY2018Q4 us-gaap Assets
Assets
2335000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
3000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2019Q1 us-gaap Cash
Cash
19276000
CY2018Q4 us-gaap Cash
Cash
1004000
CY2019Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
427000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
332000
CY2019Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1163000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
593000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
607000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
813000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
456000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
304000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1117000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1117000
CY2019Q1 us-gaap Liabilities
Liabilities
1176000
CY2018Q4 us-gaap Liabilities
Liabilities
1117000
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
69392000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
48957000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49252000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47740000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
20143000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1218000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21319000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2335000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
398000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
932000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17000000
CY2019Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
648233
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1700000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1500000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
900000
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
300000
CY2019Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
400000
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
100000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1122000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
987000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
1520000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
1919000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1520000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1919000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1512000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-1916000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.89
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.38
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1700000
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
567000
CY2019Q1 us-gaap Depreciation
Depreciation
66000
CY2018Q1 us-gaap Depreciation
Depreciation
66000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
157000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
124000
CY2019Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
95000
CY2018Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
139000
CY2019Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
570000
CY2018Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-23000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-54000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
138000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2008000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1664000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
19411000
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
869000
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
60000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0223
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0259
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.26
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.95
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
37000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
112.60
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
35000
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
18.40
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
71000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
67.26
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
16000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
186.16
CY2019Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
400000
CY2019Q1 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
900000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20280000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2019Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
18272000
CY2018Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-1681000
CY2018Q4 us-gaap Cash
Cash
1004000
CY2017Q4 us-gaap Cash
Cash
5965000
CY2019Q1 us-gaap Cash
Cash
19276000
CY2018Q1 us-gaap Cash
Cash
4284000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
8067000
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19411000
CY2019Q1 bpth Stock Issue During Period Value Warrants Exercised
StockIssueDuringPeriodValueWarrantsExercised
869000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
124000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
6275000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
157000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
340000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
406000
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
324117
CY2019Q1 bpth Accrued Vacation And Bonus
AccruedVacationAndBonus
200000
CY2019Q1 bpth Accrued Legal And Professional Fee
AccruedLegalAndProfessionalFee
100000
CY2019Q1 bpth Accrued Clinical And Preclinical Expenses
AccruedClinicalAndPreclinicalExpenses
100000
CY2019Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
100000
CY2018Q4 bpth Accrued Clinical And Preclinical Expenses
AccruedClinicalAndPreclinicalExpenses
100000
CY2018Q4 bpth Accrued Vacation And Bonus
AccruedVacationAndBonus
100000
CY2018Q4 bpth Accrued Legal And Professional Fee
AccruedLegalAndProfessionalFee
100000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1000
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
41.33
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y4M24D
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1000000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
100000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
113000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
54000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
59000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2019Q1 bpth Operating Lease Right Of Use Assets Amortization
OperatingLeaseRightOfUseAssetsAmortization
28000
CY2018Q1 bpth Operating Lease Right Of Use Assets Amortization
OperatingLeaseRightOfUseAssetsAmortization
0
CY2019Q1 bpth Increase Decrease In Operating Lease Liabilties
IncreaseDecreaseInOperatingLeaseLiabilties
28000
CY2018Q1 bpth Increase Decrease In Operating Lease Liabilties
IncreaseDecreaseInOperatingLeaseLiabilties
0
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
54000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
59000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
113000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
52000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
31000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
31000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
0
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
124000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
113000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
82000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
31000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
31000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
10000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
0
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
154000
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
29000
CY2019Q1 bpth Operating Lease Incremental Borrowing Rate Utilized
OperatingLeaseIncrementalBorrowingRateUtilized
0.080
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2814000
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2814000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
680000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
680000
CY2019Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-20
CY2019Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
common stock at a ratio of 1-for-20, and our common stock began trading on the split-adjusted basis on the Nasdaq Capital Market at the commencement of trading on January 18, 2019. All common stock share and per share amounts in our consolidated financial statements have been adjusted to give effect to the 1-for-20 reverse stock split.
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1512000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-1916000
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
BIO-PATH HOLDINGS INC
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001133818
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q1 dei Trading Symbol
TradingSymbol
BPTH
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2831356
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
28000
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
3000
CY2019Q1 us-gaap Lease Cost
LeaseCost
31000
CY2019Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
32000
CY2019Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2019Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
113000

Files In Submission

Name View Source Status
0001144204-19-026590-index-headers.html Edgar Link pending
0001144204-19-026590-index.html Edgar Link pending
0001144204-19-026590.txt Edgar Link pending
0001144204-19-026590-xbrl.zip Edgar Link pending
bpth-20190331.xml Edgar Link completed
bpth-20190331.xsd Edgar Link pending
bpth-20190331_cal.xml Edgar Link unprocessable
bpth-20190331_def.xml Edgar Link unprocessable
bpth-20190331_lab.xml Edgar Link unprocessable
bpth-20190331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv520792_10q.htm Edgar Link pending
tv520792_ex31.htm Edgar Link pending
tv520792_ex32.htm Edgar Link pending